Key result
Diabetes interventions differ significantly for HbA1c reduction but not blood pressure in modeled analysis.
Why the study?
Do common pharmacological and lifestyle interventions for diabetes differ in their reported changes in HbA1c and blood pressure?
Do common pharmacological and lifestyle interventions for diabetes differ in their reported changes in HbA1c and blood pressure?
Answers are grounded in this paper and cite their sources.
An exploratory analysis of modeled literature data found significant differences in reported HbA1c changes, but not blood pressure, across ten diabetes interventions, though these findings do not establish comparative clinical efficacy.
This exploratory secondary analysis compares reported changes in glycated hemoglobin (HbA1c), blood pressure, and insulin-related outcomes across ten pharmacological and lifestyle interventions for diabetes. Treatment-effect estimates were compiled from previously published scientific and medical sources and organized into a standardized modeling framework. During reconstruction of the original project, two demonstrable calculation errors were corrected without altering any source-derived treatment-effect values. Exploratory one-way ANOVA of the corrected modeled dataset produced F(11,24) = 2.68, p = .021 for HbA1c and F(11,24) = 1.72, p = .128 for blood pressure. Because the dataset consists of literature-derived and modeled values rather than independent patient-level observations, these statistics should not be interpreted as evidence of comparative clinical efficacy. This Zenodo record contains the reconstructed research manuscript, a cleaned publication data workbook with a correction log and source-attribution audit, and the unchanged original research poster. The original poster is preserved as a historical project output; where calculations or interpretations differ, the reconstructed manuscript and cleaned dataset provide the corrected analysis.
No takes yet. Share an insight, caveat, or question.
Siddarth Shakthimani (2026) studied Diabetes. Ten pharmacological and lifestyle interventions was evaluated on Changes in glycated hemoglobin (HbA1c) and blood pressure (p=.021 for HbA1c, .128 for blood pressure). Exploratory analysis of modeled literature-derived data across ten diabetes interventions showed significant differences for HbA1c but not for blood pressure.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: